Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer
Cancer Reports · 2025
DOI: 10.1002/cnr2.70245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Bin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hepatopancreatobiliary Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Metformin, Liver Neoplasms, Ferroptosis, Carcinoma, Hepatocellular. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TCM Science and Technology Plan Project of Zhejiang Province, Zhejiang Medical and Health Technology Plan, Ningbo Municipal Key Research and Development Plan for 2023.
Abstract (Originalsprache)
Background
Hepatocellular Carcinoma (HCC) ranks among the most prevalent human cancers and stands as the third most common cause of death related to cancer globally. Current therapies for HCC include surgical resection, local ablation, chemoembolization, liver transplantation, and molecular‐targeted therapy. Only a small number of patients are detected in the early stage, and most patients are diagnosed at the time of the middle and late stages, thus losing the opportunity for surgical treatment, which is an essential reason for the high mortality of HCC patients. Initiating cytotoxicity in cancer cells stands as a fundamental approach for tumor treatment, with the majority of research centering on apoptosis.
Aims
Since anti‐apoptotic methods often fulfill cancer cells' ability to resist anticancer drugs, research on new induction forms of regulative cell death, such as ferroptosis, is of great clinical value. Methods and Results In this study, we employed a combination of in silico molecular docking and in vitro cell validation experiments to identify three ferroptosis suppressor genes, AR, HIF1A, and CA9, as promising components of a survival prognosis model during the metformin‐induced ferroptosis process in liver cancer. Further, we discovered that AR could achieve efficient molecular docking with Metformin among these genes. Additionally, cell experiments revealed that Metformin could downregulate the protein expression level of AR.
Conclusion
This research has developed a prognostic model for ferroptosis suppressor genes through the analysis of the ferroptosis process induced by metformin in liver cancer. It also screened and validated AR as a potential molecular docking target for metformin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatopancreatobiliary Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Health Science Center, Ningbo University, Ningbo, China.
- Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Siming Zheng
Förderung
- TCM Science and Technology Plan Project of Zhejiang Province
- Zhejiang Medical and Health Technology Plan
- Ningbo Municipal Key Research and Development Plan for 2023
Zitieren
APA
Zhang, B., Yu, Z., Zhang, J., Xu, Y., Zhang, M., Dai, Z., Zhu, J., & Zheng, S. (2025). Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70245
Vancouver
Zhang B, Yu Z, Zhang J, Xu Y, Zhang M, Dai Z, et al. Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70245
BibTeX
@article{Zhang2025,
author = {Zhang, Bin and Yu, Zehao and Zhang, Jinghui and Xu, Yini and Zhang, Mengna and Dai, Zhiqi and Zhu, Jiyun and Zheng, Siming},
title = {Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin‐Induced Ferroptosis in Liver Cancer},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70245}
}
EUVIMED